Hospital Clínic de Barcelona

Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease (2025) Jessen F, Arbizu J, Boada M, Balasa M, Bennys K, Boban M, Bürger K, et al. Journal article Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trials (2025) Linggi B, Azucena S, Steere B, Verstockt B, Alsoud D, Casero D, Mcgovern D, et al. Journal article Updated classification of epileptic seizures: Position paper of the International League Against Epilepsy (2025) Beniczky S, Trinka E, Wirrell E, Abdulla F, Al Baradie R, Alonso Vanegas M, Auvin S, et al. Journal article The impact of histopathology on prognosis of squamous cell carcinoma of the larynx: can we do better? (2025) Zidar N, Thompson LD, Agaimy A, Stenman G, Hellquist H, Nadal A, Mäkitie AA, et al. Journal article, Review article Depressive Symptoms and Amyloid Pathology (2025) Wiels WA, Oomens JE, Engelborghs S, Baeken C, Von Arnim CA, Boada M, Didic M, et al. Journal article The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study (2025) Rangelova E, Stoop TF, van Ramshorst TM, Ali M, van Bodegraven EA, Javed AA, Hashimoto D, et al. Journal article Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study (2025) Merz M, Albici AM, von Tresckow B, Rathje K, Fenk R, Holderried T, Müller F, et al. Journal article Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial (2025) Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, et al. Journal article Revidierte Klassifikation epileptischer Anfälle: Positionspapier der Internationalen Liga gegen Epilepsie (2025) Beniczky S, Trinka E, Wirrell E, Abdulla F, Al Baradie R, Alonso Vanegas M, Auvin S, et al. Journal article, Review article Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article